O1-4-2 [Encore]Brigatinib (BRG) vs Crizotinib (CRZ) in Patients (Pts) With ALK Inhibitor-Naive Advanced ALK+ NSCLC from ALTA-1L
James C H Yang,Hye R Kim,Myung-Ju Ahn,Ji-Youn Han,Maximilian J Hochmair,Ki H Lee,Angelo Delmonte,Maria R Garcia Campelo,Dong-Wan Kim,Enriqueta Felip,Raffaele Califano,Alexander Spira,Scott Gettinger,Marcello Tiseo,Jeff Haney,David Kerstein,Sanjay Popat,D R Camidge ANNALS OF ONCOLOGY（2019）
AI 理解论文
溯源树
样例
